Article
Where we were, where we are, where we are going: progress in multiple myeloma.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting - 1 Jan 2014
Bergsagel P Leif
Abstract excerpt
The celebration of the 50th anniversary of the founding of the American Society of Clinical Oncology provides the occasion to review the progress that has been made in the biology and treatment of multiple myeloma. With the advent of melphalan and cyclophosphamide in the early 1960s the median survival of patients with multiple myeloma more than doubled from 10 months to approximately 24 months. Throughout...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.